1. Biomass and bioenergy potential of cassava waste in Nigeria: Estimations based partly on rural-level garri processing case studies. (May 2017) Authors: Ozoegwu, C.G.; Eze, C.; Onwosi, C.O.; Mgbemene, C.A.; Ozor, P.A. Journal: Renewable & sustainable energy reviews Issue: Volume 72(2017) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-1268 Primary radiation therapy in stage I/II indolent orbital lymphoma: a single-center analysis. (April 2019) Authors: Eze, C.; Friedrich, I.; Reitz, D.; Belka, C.; Li, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-1372 External Validation of a Survival Score for Limited Disease Small Cell Lung Cancer (LD-SCLC). (April 2019) Authors: Käsmann, L.; Abdo, R.; Eze, C.; Dantes, M.; Taugner, J.; Gennen, K.; Roengvoraphoj, O.; Rades, D.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-1374 ECOG-PS and its changes in inoperable stage III NSCLC patients treated with chemoradiotherapy. (April 2019) Authors: Käsmann, L.; Taugner, J.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. EP-1375 Heterogeneity score in inoperable stage III NSCLC patients treated with definitive chemoradiotherapy. (April 2019) Authors: Taugner, J.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Gennen, K.; Karin, M.; Tufman, A.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EP-1515 Substantial impact of 68Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer. (April 2019) Authors: Schmidt-Hegemann, N.; Eze, C.; Li, M.; Rogowski, P.; Schaefer, C.; Stief, C.; Ganswindt, U.; Bartenstein, P.; Belka, C.; Ilhan, H. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0144: Maximum response and PCI are important prognostic factors in LD SCLC patients staged with cMRI. (April 2016) Authors: Eze, C.; Roengvoraphoj, O.; Niyazi, M.; Gerum, S.; Hildebrandt, G.; Fietkau, R.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD-0398 Accumulated dose comparison of stereotactic MRgRT and proton therapy for central lung tumors. (May 2022) Authors: Rabe, M.; Palacios, M.A.; van Sörnsen de Koste, J.; Eze, C.; Hillbrand, M.; Belka, C.; Landry, G.; Senan, S.; Kurz, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PD-0810 Salvage Therapies for PSMA PET/CT-positive nodal-only recurrent prostate cancer: Impact on survival, functional outcomes and health-related quality of life. (August 2021) Authors: Schmidt-Hegemann, N.; Trapp, C.; Rogowski, P.; Eze, C.; Milow, J.; Buchner, A.; Li, M.; Ilhan, H.; Wenter, V.; Stief, C.G.; Belka, C.; Kretschmer, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0780 Prognostic value of PD-L1 expression in locally advanced NSCLC treated with chemoradiotherapy. (April 2019) Authors: Gennen, K.; Käsmann, L.; Eze, C.; Dantes, M.; Roengvoraphoj, O.; Taugner, J.; Neumann, J.; Mille, E.; Tufman, A.; Huber, R.M.; Orth, M.; Reu, S.; Niyazi, M.; Belka, C.; Manapov, F. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗